VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,957,641 | +2254.5% | 1,559,184 | +2534.5% | 0.54% | +1362.2% |
| Q2 2023 | $1,782,030 | -87.9% | 59,184 | -87.0% | 0.04% | -90.4% |
| Q1 2023 | $14,703,075 | -72.4% | 454,500 | -76.6% | 0.39% | -82.4% |
| Q2 2022 | $53,287,000 | -28.6% | 1,946,200 | 0.0% | 2.19% | -44.9% |
| Q1 2022 | $74,637,000 | +133.0% | 1,946,200 | +94.6% | 3.98% | -82.8% |
| Q4 2021 | $32,030,000 | +8.7% | 1,000,000 | 0.0% | 23.21% | +506.2% |
| Q3 2021 | $29,470,000 | +8.4% | 1,000,000 | +25.0% | 3.83% | -48.6% |
| Q2 2021 | $27,184,000 | -54.1% | 800,000 | -20.7% | 7.45% | -14.3% |
| Q1 2021 | $59,168,000 | -46.7% | 1,008,200 | -67.3% | 8.69% | -60.9% |
| Q4 2020 | $110,941,000 | +2119.7% | 3,080,000 | +1528.8% | 22.25% | +5172.5% |
| Q3 2016 | $4,998,000 | – | 189,092 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |